RSV
Clinical trials for RSV explained in plain language.
Never miss a new study
Get alerted when new RSV trials appear
Sign up with your email to follow new studies for RSV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New RSV mRNA vaccine enters first human safety tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial will test the safety of a new RSV mRNA vaccine in 60 healthy adults aged 18 and older. Participants will receive either a low dose, high dose, or a placebo (saline) shot. The study aims to see if the vaccine causes any side effects, paving the way for large…
Matched conditions: RSV
Phase: PHASE1 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple vaccine slash COPD attacks?
Disease control Not yet recruitingThis study tests whether a single dose of the RSV vaccine (Arexvy) can reduce moderate-to-severe COPD flare-ups in people who have frequent attacks. Researchers will enroll 320 high-risk patients aged 50+ and follow them for one year. Half will get the vaccine plus standard care,…
Matched conditions: RSV
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New pill could help babies fight RSV faster
Disease control Not yet recruitingThis study tests an experimental oral drug called zelicapavir in 150 children aged 1 month to 3 years who have respiratory syncytial virus (RSV). The drug aims to stop the virus from multiplying and speed up recovery. Half the children will get the drug, half a placebo, and resea…
Matched conditions: RSV
Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Could a single At-Home swab detect COVID, flu, and RSV?
Diagnosis Not yet recruitingThis study will test a new at-home diagnostic test that aims to detect five respiratory viruses—COVID-19, influenza A and B, RSV, and rhinovirus—from a single nose swab. About 2,000 people with cold or flu symptoms will provide samples in simulated home environments. The test's a…
Matched conditions: RSV
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
10,000 adults to be tracked for RSV – could pave way for vaccine decisions
Knowledge-focused Not yet recruitingThis study will track 10,000 adults in Hong Kong with respiratory symptoms to measure how often RSV causes illness and how severe it gets. Researchers will collect nose and throat samples and blood tests over several weeks. The goal is to fill knowledge gaps about RSV in adults a…
Matched conditions: RSV
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC